Kevin Mellert (K Mellert)

Years Active: 2017-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah Bette, Luisa Haase, Juliane Nell, Thomas Grieser, Alexandra von Baer, Markus Schultheiss, Ralf Marienfeld, Peter Möller, Thomas F E Barth, Kevin Mellert
Impact of CDK Inhibitors on TBXT Expression in Chordoma Cell Lines Including the First Stable Cell Line of a High-Grade Chordoma. Diagnostics (Basel, Switzerland) 14 (10) (2024)
Sarah Bette, Luisa Haase, Juliane Nell, Thomas Grieser, Alexandra von Baer, Markus Schultheiss, Ralf Marienfeld, Peter Möller, Thomas F E Barth, Kevin Mellert
Impact of CDK Inhibitors on TBXT Expression in Chordoma Cell Lines Including the First Stable Cell Line of a High-Grade Chordoma. Diagnostics (Basel, Switzerland) 14 (10) (2024)
Kevin Mellert, Melanie Martin, Jochen K Lennerz, Manuel Lüdeke, Annette M Staiger, Markus Kreuz, Markus Löffler, Norbert Schmitz, Lorenz Trümper, Alfred C Feller, Sylvia Hartmann, Martin-Leo Hansmann, Wolfram Klapper, Harald Stein, Andreas Rosenwald, German Ott, Marita Ziepert, Peter Möller
The impact of SOCS1 mutations in diffuse large B-cell lymphoma. British journal of haematology 187 (5) (2019)
D Jäger, A Lechel, U Tharehalli, C Seeling, P Möller, T F E Barth, Kevin Mellert
U-CH17P, -M and -S, a new cell culture system for tumor diversity and progression in chordoma. International journal of cancer 142 (7) (2017)

Kevin Mellert.css-eqlu8i{font-size:small;padding-left:4px;} (K Mellert)